Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients

NCT04875858 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

254

Enrollment

OTHER

Sponsor class

Conditions

Pneumococcal Infections

Interventions

DRUG: ProDiax-23 (PPSV23)

Sponsor

Korea University Guro Hospital

Collaborators

[object Object]